Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep658 | Female Reproduction | ECE2016

Sex hormone and steroid precursor measurement by simple and rapid liquid chromatography-tandem mass spectrometry (Lc-Ms/Ms) method: comparison with current routine immunoassays

Fanelli Flaminia , Mezzullo Marco , Fazzini Alessia , Baccini Margherita , Gambineri Alessandra , Vicennati Valentina , Pelusi Carla , Pasquali Renato , Pagotto Uberto

Though LC-MS/MS is replacing immunoassays for major glucocorticoids and androgens routine assessment, the measurement of other sex steroids and precursors is still challenging and available only in experienced research laboratories. Our aim was to develop a simple-prep and rapid 2D-LC-MS/MS method for the simultaneous measurement of estrone (E1), estradiol (E2), dihydrotestosterone (DHT) and 17OHpregnenolone.Serum volumes of 300ul were spiked with intern...

ea0037ep204 | Reproduction, endocrine disruptors and signalling | ECE2015

Salivary cortisol response to psychological stress in late adolescent and young women: impact of menstrual irregularity, hirsutism, and hyperandrogenaemia

Mezzullo Marco , Gambineri Alessandra , Fanelli Flaminia , Repaci Andrea , Prontera Olga , Di Dalmazi Guido , Pagotto Uberto , Pasquali Renato

Hyperandrogenic disorders cause psychological implication in young girls, limiting the quality of life. Salivary cortisol (SalF) testing was proved to be useful in the evaluations of acute stress responses. Aim of this study was to investigate SalF responses to a stressor event in late adolescent females. We selected 165 drug-free females aged 16–19 years from a cross-sectional epidemiological study. Saliva was collected in the morning before and after a stressor event co...

ea0035p639 | Female reproduction | ECE2014

rhAMH inhibits CYP19 and P450scc mRNA expression in granulosa-lutein cells treated with gonadotropin

Sacchi Sandro , Marinaro Federica , Tagliasacchi Daniela , Bastai Francesca , Marsella Tiziana , Argento Cindy , Tirelli Alessandra , Giulini Simone , Marca Antonio La

Anti-Mullerian hormone (AMH), a member of transforming growth factor β (TGF-β), shows different sex-related functions. In male, from the fetal development till the puberty, the expression of AMH by Sertoli cells causes regression of Mullerian ducts with subsequent testicular differentiation. Mainly studied in female, AMH produced by ovarian granulosa cells inhibits both initiation of primordial follicle growth and the FSH-stimulated follicle growth. Moreover, recent ...

ea0070aep694 | Pituitary and Neuroendocrinology | ECE2020

Micromegaly or acromegaly? A retrospective longitudinal study on clinical aspects and comorbidities in a large cohort of patients referred to a single tertiary center

Carosi Giulia , Sala Elisa , Mangone Alessandra , Del Sindaco Giulia , Mungari Roberta , Cremaschi Arianna , Ferrante Emanuele , Arosio Maura , Mantovani Giovanna

Introduction: The diagnosis of acromegaly is confirmed in the presence of high IGF-1 levels and inadequate suppression of growth hormone (GH) after glucose load. According to guidelines, a GH nadir (GHn)>0.4 ng/ml is considered diagnostic with ultrasensitive assays. However, some acromegalic patients with lower GHn, also called ‘micromegalic’, are reported, but a systematic collection of their clinical features is unavailable.Aim of the s...

ea0070aep782 | Reproductive and Developmental Endocrinology | ECE2020

New data in turner syndrome: Results from a long-term prospective observational study from diagnosis to adulthood

Corzani Francesca , Cecchetti Carolina , Oriolo Claudia , Altieri Paola , Perri Annamaria , Scarano Emanuela , Mazzanti Laura , Pagotto Uberto , Gambineri Alessandra

Turner syndrome (TS), one of the most frequent chromosomal aberrations in females, is characterized not only by structural abnormalities (somatic and congenital) but also by acquired comorbidities, such as metabolic disorders, cardiovascular alterations, autoimmune diseases, osteoporosis, and malignancies. The prevalence of structural abnormalities that usually complicate TS at diagnosis is well known. However, the prevalence of acquired complications, that may appear at any a...

ea0070aep820 | Reproductive and Developmental Endocrinology | ECE2020

BMI may be a better predictor of cardiovascular risk than PCOS phenotype in a population of reproductive age PCOS patients

Pandurevic Srdjan , Pizzi Carmine , Fanelli Flaminia , Vicennati Valentina , Pelusi Carla , Di Dalmazi Guido , Pagotto Uberto , Gambineri Alessandra

Introduction: Women with polycystic ovary syndrome (PCOS) are considered to have increased risk of cardiovascular disease (CVD), even though the syndrome encompasses hugely varying phenotypes. Research into CVD prevention demonstrated a variety of biochemical and ultrasound (US) markers predicting risk in the general population, but those are sparsely utilised for PCOS, in part due to the patients’ therapeutic goals.Aim: To evaluate if PCOS type or...

ea0070ep379 | Reproductive and Developmental Endocrinology | ECE2020

Semen quality improvement after weight loss by very low-calorie ketogenic dietary: A report of two cases

Renck Alessandra , Afonso Teixeira Thiago , Risso Pariz Juliana , Barbosa Trarbach Ericka , Hallak Jorge , Maria Frade Costa Elaine

Considered as the biggest public health problem, the pandemic growth of obesity is associated to decline of male fertility potential over the last 50 years. Thus far, the effect of weight loss on semen parameters is still controversial and poorly understood. In this study we report the effect of significant weight loss on semen parameters of two obese men with metabolic syndrome. The patients followed to a very low-calorie ketogenic diet (VLCKD) according to a commercial weigh...

ea0032p145 | Calcium and Vitamin D metabolism | ECE2013

Experience in the treatment of primary hyperparathyroidism with cinacalcet: data after 12 months of treatment

Luque-Fernandez Ines , Garcia-Martin Antonia , Luque-Pazos Alessandra , Sastre-Marcos Julia , Vicente-Delgado Almudena , Marco-Martinez Amparo , Canovas Barbara

Introduction: Cinacalcet is an oral calcimimetic indicated in treatment of primary hyperparathyroidism if patients do not accept surgery, do not carry out the surgical criteria, there is failure of previous surgery or serious comorbidity that makes surgery impossible.Methods: Descriptive study that included 20 patients with primary hyperparathyroidism who had complete at least 12 months of treatment with cinacalcet for different reasons (eight patients r...

ea0032p758 | Obesity | ECE2013

Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a meta-analytic study

Corona Giovanni , Rastrelli Giulia , Monami Matteo , Saad Farid , Luconi Michaela , Lucchese Marcello , Sforza Alessandra , Forti Gianni , Mannucci Edoardo , Maggi Mario

Introduction: Few randomised clinical studies have evaluated the impact of diet and physical activity on testosterone levels in obese men with conflicting results. Conversely, studies on bariatric surgery in men generally showed an increase in testosterone levels. The aim of the present study is to perform a systematic review and meta-analysis of available trials on the effect of body weight loss on sex hormones levels.Methods: An extensive Medline searc...

ea0032p941 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Clinical presentation, treatment approach and outcomes of patients with prolactinomas in real-life clinical practice: a single center experience

Vicente Almudena , Satre Julia , Zaballos Florentino , Luque Ines , Luque Alessandra , Castro Enrique , Maqueda Esther , Marco Amparo , Lopez Jose

Introduction: Generously supported by IPSEN)-->Prolactin (PRL) -secreting adenomas are about 40% of all pituitary adenomas. Their clinical symptoms are mainly related to development of secondary hypogonadism and/or tumor mass effects. Dopamine agonists (DA) are first-line drugs for prolactinoma patients due to their effectiveness in normalizing PRL levels and shrinking tumour mass. Surgery is an option for DA failure or tumour mass e...